The European and Developing Countries Clinical Trials Partnership (EDCTP) announced it is making Euro 5 million available to enable EU countries to stage clinical trials in HIV/AIDS, malaria and tuberculosis, in collaboration with African partner countries.
EDCTP says the aim is to increase the efficiency of research into the three diseases and to avoid duplication. It is interested in funding projects to accelerate clinical trials in HIV/AIDS, malaria and tuberculosis interventions in sub-Saharan Africa that integrate member states’ national programmes; strengthen north-south partnerships, coordinate and network with African researchers and create sustainable capabilities within African institutions and research centres.
The EDCTP member states are Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the UK.
The African countries linked with the scheme are: Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Democratic Republic of Congo, Republic of Congo, Ivory Coast, Equatorial Guinea, Eritrea, Ethiopia, Gabon, the Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, Sudan, Swaziland, Tanzania, Togo, Uganda, Zambia and Zimbabwe.